- Oxybate Treatment for Cataplexy and EDS in Narcolepsy |XYREM®
XYREM® (sodium oxybate) is approved for use in adults and children ages 7 and older to help treat cataplexy and EDS in narcolepsy See XYREM® prescribing information BOXED Warning about serious side effects, CNS depression, misuse and abuse
- Sodium oxybate: Dosage, Side Effects, Warnings - Drugs. com
Sodium oxybate (brand name Xyrem or Lumryz) may be used to treat narcolepsy symptoms such as suddenly weak or paralyzed muscles (cataplexy) or excessive daytime sleepiness (EDS)
- Xyrem (sodium oxybate) oral solution CIII Label
Xyrem is a Schedule III controlled substance and is the sodium salt of gamma hydroxybutyrate (GHB), a Schedule I controlled substance Because of the risks of CNS depression, abuse, and misuse,
- Sodium Oxybate Treatment for Cataplexy and EDS in Narcolepsy | XYREM®
Learn about XYREM® (sodium oxybate oral solution), and how it can help your narcolepsy patients’ cataplexy and excessive daytime sleepiness (EDS) symptoms See XYREM® prescribing information BOXED Warning about serious side effects, CNS depression, misuse, and abuse
- Xyrem: Uses, Dosage, Side Effects, Warnings - Drugs. com
Xyrem (sodium oxybate) is an oral prescription solution that may be used to treat cataplexy or excessive daytime sleepiness (EDS) in adults and children aged 7 years and older with narcolepsy
- Xyrem Patient Tips: 7 things you should know - Drugs. com
Xyrem is a brand (trade) name for sodium oxybate which is the sodium salt of gamma-hydroxybutyrate (GHB) Xyrem may be used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness
- Sodium Oxybate (Xyrem): Narcolepsy Drug Side Effects Dosage
Xyrem (sodium oxybate) is the sodium salt of gamma hydroxybutyrate (GHB) Abuse of GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death
- XYREM (sodium oxybate) oral solution, CIII - Food and Drug Administration
Xyrem is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy (1)
|